% Expired Patents = 33.3

CIPO Patents = 1

EPO Patents = 3

Trademarks = 1

Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

David Festus Charles Moffat (3 out of 16 patents)

Stéphane Pintat (2 out of 6 patents)

Stephen John Davies (2 out of 15 patents)

4. Martin John Perry (1 out of 1 patent)

5. Stephen Mark Anderton (1 out of 1 patent)

6. Clare Louise Doris (1 out of 1 patent)

7. Carl Leslie North (6 patents)

8. David Festus Moffat (0 patent)

9. Stephane Pintat (0 patent)

3 patents: Sort by Forward Citations

1. 11382902 - Treatment of cancer by stimulation of IL-12 production (2022-07-12),

2. 10370332 - Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof (2019-08-06),

3. 9896417 - Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof (2018-02-20),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#10 in Windsor

#4,894 in United Kingdom

Windsor, United Kingdom

Macrophage Pharma Limited

Forward Citations = 1

6 inventors:

David Festus Charles Moffat (3 out of 16 patents)

Stéphane Pintat (2 out of 6 patents)

Stephen John Davies (2 out of 15 patents)

4. Martin John Perry (1 out of 1 patent)

5. Stephen Mark Anderton (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Macrophage Pharma Limited. Retrieved from https://idiyas.com/company/macrophage-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]